Having amassed more than 2 million patient years of data, Novartis sits on what is probably one of the most valued treasures in the pharmaceutical industry. But to make sense of it, artificial intelligence, or AI, is only part of the solution. Asking the right questions is crucial to getting the most out of the data. Likewise, when it comes to leprosy, data is only part of the solution to eliminating this disease. But used in the right fashion, it can make a difference in the fight to make leprosy a thing of the past once and for all.
Published on 22/03/2021
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.